{
    "SPADE_UN_19648": {
        "Sequence Information": {
            "Peptide Name": "Safencin (48-70)[G2,18W;E4K]",
            "Sequence": "AWKKTIRQYLKNEIKKKWRKAVIAW",
            "Sequence Length": 25,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "A0A1L6ZNG9",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/A0A1L6ZNG9",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48.",
                    "Pubmed ID": "29463889",
                    "Reference": "J Antibiot (Tokyo). 2018;:",
                    "Author": "Fields FR, Carothers KE, Balsara RD, Ploplis VA, Castellino FJ, Lee SW",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29463889"
                }
            ],
            "Mass": 3186.84,
            "PI": 10.79,
            "Net Charge": 8,
            "Hydrophobicity": -0.98,
            "Frequent Amino Acids": "KAI",
            "Absent Amino Acids": "CDFGHMOPSU",
            "Basic Residues": 9,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 8,
            "Polar Residues": 17,
            "Positive Residues": 9,
            "Negative Residues": 1,
            "SPADE ID": "SPADE_UN_19648",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_19648",
                    "Similarity": 1.0,
                    "Sequence": "AWKKTIRQYLKNEIKKKWRKAVIAW"
                },
                {
                    "SPADE_ID": "SPADE_N_12070",
                    "Similarity": 0.96,
                    "Sequence": "AWKKTIRQYLKNKIKKKWRKAVIAW"
                },
                {
                    "SPADE_ID": "SPADE_N_14205",
                    "Similarity": 0.96,
                    "Sequence": "AWKKTIRQYLKNEIKKKGRKAVIAW"
                }
            ],
            "Hemolytic Activity": "Human keratinocytes HaCat:8% Cytotoxicity=10 µM,Sheep erythrocytes:25% Hemolysis=10 µM",
            "Target Organism": "Escherichia coli BL21(MIC=2µM),Xanthomonas axonopodis pv. phaseoli ATCC 9563(MIC=1µM),Pseudomonas aeruginosa PAO1(0-10% Inhibition=8µM),Streptococcus pyogenes GAS M1T1(MIC=8µM),Pseudomonas syringae(MIC=>=8µM),Staphylococcus aureus(0-10% Inhibition=8µM)"
        }
    }
}